跳至主要内容
临床试验/CTRI/2012/04/002614
CTRI/2012/04/002614已完成1/2 期

A Prospective, Multicentric, Open Label, Randomized, Bio-Interventional, Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For Treatment Of Androgenetic Alopecia (AGA)

Kasiak Research Pvt Ltd2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年1月25日最近更新:
适应症

试验速览

阶段
1/2 期
状态
已完成
入组人数
20
试验地点
2
主要终点
1.Improvement in Calibre & Density of Hair as assessed by Folliscope

研究概览

简要总结

This is a multicentre, openlabel, randomized, pilot study to evaluate safety and efficacy of HumanPlatelet Lysate (HPL) in subjects with Androgenetic Alopecia. The study isbeing conducted at 2 centers in India. The primary endpoints are Improvement inCaliber & Density of hair and Improvement in Photographic assessment from randomizationto end of study. The secondary endpoints are Physicians and Patients selfassessment score.

研究设计

研究类型
Interventional
分配方式
Permuted block randomization, fixed
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
Male

入选标准

  • 1.Male subjects, aged between 18 to 50 years (both inclusive) and in general good health 2.Subjects willing to refrain from other AGA treatments during the entire study duration 3.Subjects who are willing to give informed consent and adhere to the study protocol.

排除标准

  • 1.Subjects aged <18 or > 50 years
  • Subjects with dermatological disorder of scalp that might interfere with study evaluation 3.Subjects on Anti-coagulant therapy 4.Subjects with clinically significant medical or psychiatric disease as determined by the investigator.
  • Subjects with dermatological disorder of scalp that might interfere with study evaluation
  • Subjects unwilling to or unable to comply with the study protocol.

结局指标

主要结局

1.Improvement in Calibre &amp; Density of Hair as assessed by Folliscope

时间窗: End of Study- 6 Months

2.Photographic assessment from randomization to end of study

时间窗: End of Study- 6 Months

次要结局

  • 1.Physician’s assessment score(2.Patient’s self assessment score)

研究者

申办方类型
Other [Biotechnology company ]

研究点 (2)

Loading locations...

相似试验